When state social service workers asked a judge to hold their son Franklin against his will at Sunland Center, a North Florida institution for disabled people, Eddie and Charlotte Weekley handed him over voluntarily. ''They said it's a secure facility,'' Eddie Weekley said. ``They said my son would be safe there.'' Instead, they lost him. That was more than a year ago.
Franklin's medical records for 2001 show he was on two psychiatric drugs, Paxil and Topamax. The purpose of the drugs, records show: ``For behavior control.'' ''He stuttered,'' Eddie Weekley said. ``He couldn't talk.''
The Weekleys, and some caregivers, say they nevertheless understood what Franklin wanted. ''Franklin always wanted to go home,'' said Donna Fassett, executive director of The ARC Gateway in the Florida Panhandle, which offered services to Franklin before he was sent to Sunland.
On the evening of Dec. 5, 2002, a noticeably anxious Franklin called home, but was unable to reach his father, Charlotte Weekley said. When the father called back an hour or two later, workers at the institution refused to allow him to speak to Franklin. The next morning, Sunland administrators reported that Franklin was missing. They say he simply wandered out of the campus, which is surrounded by woods and does not have a fence. The Jackson County Sheriff's Office dispatched deputies on horseback, all-terrain vehicles and a helicopter in search of the teen.
Fassett said one Pensacola television station reported Franklin's story, but local newspapers showed little interest.
See this report to find out more about the story of this missing child.
Sunday, December 21, 2003
The Disapperance of a teenpsych patient in Florida
3,000 Scots children on 'zombie' drug
Prescriptions of the psychiatric drug Ritalin to children have increased by almost 70% in the past four years in Scotland, heightening fears that a generation of ‘zombie’ youngsters is being created. Despite these fears, Scottish GPs are prescribing Ritalin and its generic equivalents to ever-increasing numbers of children. The latest Scottish Executive figures suggest there are 30,000 annual prescriptions of Ritalin-type drugs annually, up 68% on 1999.
As reported in the story at the link, MSP Adam Ingram, who asked health minister Malcolm Chisholm for the latest figures, said: "What is the reason for this huge increase? Is it an outbreak of ADHD, which I would doubt? Or is it just that people are saying let’s go down this road of managing children’s behaviour in this way?"
Wednesday, December 17, 2003
Glaxo Chief: Our Drugs Do Not Work on Most Patients
A senior executive with Britain's biggest drugs company has admitted that most prescription medicines do not work on most people who take them. Allen Roses, worldwide vice-president of genetics at GlaxoSmithKline (GSK), said fewer than half of the patients prescribed some of the most expensive drugs actually derived any benefit from them.
It is an open secret within the drugs industry that most of its products are ineffective in most patients but this is the first time that such a senior drugs boss has gone public. His comments come days after it emerged that the NHS drugs bill has soared by nearly 50 per cent in three years, rising by £2.3bn a year to an annual cost to the taxpayer of £7.2bn. GSK announced last week that it had 20 or more new drugs under development that could each earn the company up to $1bn (£600m) a year.
Drugs for Alzheimer's disease work in fewer than one in three patients, whereas those for cancer are only effective in a quarter of patients. Drugs for migraines, for osteoporosis, and arthritis work in about half the patients, Dr Roses said. Most drugs work in fewer than one in two patients mainly because the recipients carry genes that interfere in some way with the medicine, he said.
"The vast majority of drugs - more than 90 per cent - only work in 30 or 50 per cent of the people," Dr Roses said. "I wouldn't say that most drugs don't work. I would say that most drugs work in 30 to 50 per cent of people. Drugs out there on the market work, but they don't work in everybody."
This goes against a marketing culture within the industry that has relied on selling as many drugs as possible to the widest number of patients - a culture that has made GSK one of the most profitable pharmaceuticals companies, but which has also meant that most of its drugs are at best useless, and even possibly dangerous, for many patients.
Saturday, December 13, 2003
Baughman Dispels The Myth of ADHD
Insight Magazine has an excellent interview with Dr. Fred A. Baughman Jr, on the subject of ADHD
Retired California neurologist Fred A. Baughman Jr. fired off a letter in January 2000 to U.S. Surgeon General David Satcher in response to Satcher's Report on Mental Illness. "Having gone to medical school," Baughman wrote, "and studied pathology — disease, then diagnosis — you and I and all physicians know that the presence of any bona fide disease, like diabetes, cancer or epilepsy, is confirmed by an objective finding — a physical or chemical abnormality. No demonstrable physical or chemical abnormality: no disease!
"You also know, I am sure," Baughman continued, "that there is no physical or chemical abnormality to be found in life, or at autopsy, in 'depression, bipolar disorder and other mental illnesses.' Why then are you telling the American people that 'mental illnesses' are 'physical' and that they are due to 'chemical disorders?'"
Good article as a resource
Thursday, December 11, 2003
Canadian psychologist stripped of licence faces misconduct charges in Ohio
A disgraced Canadian psychologist who lost his licence to practise in the 1980s after having sex with anorexic patients is now facing charges of sexual misconduct in the United States.
David Garner, 56, considered one of the world's leading experts on eating disorders, has been accused by the Ohio Board of Psychology of 15 ethics violations. They include multiple counts of negligence, impairment and engaging in sexual misconduct since September 2001 with a woman Garner supervises at the River Centre Clinic in Sylvania, Ohio. He's also accused of buying a $108,000 US condominium for the woman, who says their relationship was consensual.
Ontario regulators stripped Garner of his licence in 1989 for having sexual relations with a patient while he operated an eating disorder clinic in Toronto. At the time, Garner was already serving a two-year suspension after having sex with an 18-year-old anorexic patient. The suspension was one of the most severe penalties handed out by the Ontario Board of Examiners of Psychology, forcing him to resign from the Toronto General Hospital and the University of Toronto.
Garner is now a director at the River Centre Clinic, which specializes in treating eating disorders, but he's stepped down in light of the newest accusations.
Monday, December 08, 2003
Ritalin use in preteen children may lead to depression later in life
Ritalin use in preteen children may lead to depression later in life, studies of rats suggest.
It's an open question whether what passes for depression in lab rats has anything to do with depression in humans. But early use of Ritalin and other stimulant drugs seems to permanently alter animals' brains. That raises concerns that the same thing might be happening in children who take these drugs for attention deficit hyperactivity disorder (ADHD).
The findings come from a research team led by William A. Carlezon Jr., PhD, director of the behavioral genetics laboratory at McLean Hospital and associate professor at Harvard Medical School. The study appears in the Dec. 15 issue of Biological Psychiatry.
See the NIH Press Release here
Monday, December 01, 2003
Drug firms pay doctors to sign 'independent' clinical studies
A British psychiatrist was doing research on possible dangers of antidepressant drugs when a representative of a drug manufacturer came to him with an offer of help. You're a busy guy, the company rep said. Here's some background on our product.
He e-mailed Dr. David Healy a finished 12-page review paper with graphs and footnotes, ready to present at an upcoming conference. And for convenience, Healy's name appeared as the sole author, even though the psychiatrist had never seen a single word of it before.
The drug company wanted its advertising to look like an independent study -- a "massive" scientific fakery that top medical journals condemn because it prevents doctors from getting the straight facts on medicines they prescribe.
Healy looked a gift horse in the mouth. Fearing the drug company was too easy on its own multimillion-dollar product, he did his own writing. But the ghostwritten paper appeared verbatim at the conference and in a psychiatric journal anyway -- under another doctor's name.
The drug industry is quietly paying "independent" doctors to sign their names to work they never did -- and keep their mouths shut.
"That of course is unbelievably corrupt and horrible," said Dr. Drummond Rennie, deputy editor of the Journal of the American Medical Association.
Sunday, November 30, 2003
Psych in Fued vs Injured Neighbor
Jean Pierre Villar, a man in a fued with his neighbor, psychologist Holli Bodner, has run into financial problems when Bodner tried to have Villar commited for a forced mental exam under Florida Law.
On Nov. 14, Villar filed a complaint with the Sheriff's Office, alleging that his neighbor, psychologist Holli Bodner, lied on the form she filed to have him committed under the state's Baker Act. Deputies took him to Manatee Glens and then to Blake Medical Center, but he was released before being evaluated. Since then, he's hired a lawyer to prepare a suit against the Sheriff's Office and Bodner.
Jean Pierre Villar moved to Florida more than a year ago to get surgery and rehabilitation for a long-ignored work-related back injury. The incident with sheriff's deputies took place within weeks after the surgery.
After he was committed through the Baker Act, Villar's workers' compensation payments were cut off. The insurance company said his new injuries do not appear to be related to his construction work-related injury, but appear to be caused by the commitment, Bruce Zeidman, Villar's workers' compensation lawyer, said last month.
Villar says the deputies bent him over to restrain him, further damaging his back. The nerve damage spread from one leg to two and is attacking his left arm, causing uncontrollable shaking and "horrible pain," he said.
One wonder's watch the psych said to the cops to have a man in such obvious pain treated so roughly.
New Zealand's black market for children's Ritalin
New Zealand parents of children prescribed methylphenidate for ADHD are selling it to supplement their state benefits. There is anecdotal evidence that children had been selling it at school. "There's quite a brisk illegal market for Ritalin. Methamphetamine and Ritalin are the biggest trend in drug use, and would be second behind cannabis."
New Zealand's use of attention deficit hyperactivity disorder (ADHD) drugs such as Ritalin is spiralling. Figures from government drug-buying agency Pharmac show 17 per cent more methylphenidate – commonly known at Ritalin and Rubifen – was dispensed in the 12 months ended July than in the previous year. Thirty-three times more methylphenidate is now dispensed to treat children with ADHD than there was a decade ago when estimates suggested only 242 patients were receiving the drug. Many patients are now likely to be prescribed both short- and long-acting strengths and hold two prescriptions. Now Pharmac estimates 5550 patients are taking ADHD drugs – up 15 per cent on last year.
Health experts spoken to by The Press are unconcerned at the increased prescribing of methylphenidate but do worry about its illicit use through the black market. Parents selling drugs prescribed for their behaviourally troubled children are fuelling the black market trade in Ritalin.
National Addiction Centre director and psychiatrist Associate Professor Doug Sellman said the more methylphenidate was used for ADHD, the more families would trade it. "The temptation to sell Johnny's medication is stronger in poorer families, and ADHD tends to be found more in lower socio-economic families."
Psychopaths twice as likely to re-offend after treatment
According to this article in the Telegraph, psychopaths such as serial killers are twice as likely to reoffend after treatment in British prison rehabilitation programs as psychopaths who do not take part in such programs.
Dr Robert Hare, a Canadian professor of psychology who has studied psychopaths for 35 years, believes that participating in such courses actually increases the chances that a psychopath will reoffend when he gets out.
Within two years of their release, psychopaths who go on such courses reoffend at almost twice the rate as those who do not. More than 80 per cent of the psychopaths who complete therapeutic courses reoffend soon after release. However, fewer than half of those who do not undergo such courses go on to reoffend.
Yet the offenders who had been on the therapy courses had convinced prison and psychiatric staff that they had "genuinely addressed their own offending behaviour", and were "responding positively to therapy". Indeed, those offenders who were most successful at convincing their therapists that they had gained insight into their own behaviour and changed for the better actually went on to reoffend at the highest rates.
{...}
"The psychiatric profession and its associates are very reluctant to admit they are wrong or that they have made a mistake, let alone to accept that they have been conned by a psychopath," says Dr Hare. "Therapists tend to insist that their diagnosis was right at the time and on the evidence they had - even when that is manifestly disproved by subsequent events."
So it looks like they just get really good at learning the psycho-babble jargon, and thus are more expert at manipulating the therapists.
This speaks volumes about the effectiveness of the therapists and the "science" they practice.
Saturday, November 29, 2003
New Expensive Drugs no better than Old Inexpensive Drugs
As seen in the New Hampshire Telegraph
An older, inexpensive drug is as effective/ineffective at treating the symptoms of schizophrenia as a newer, more popular drug that costs about 100 times more, according to a new report. The study, published in Wednesday’s issue of the Journal of the American Medical Association, also found no difference in quality of life between those given the newer drug, olanzapine, and those given the older drug, haloperidol, plus another drug to control side effects. Haloperidol treatment was $3,000 to $9,000 cheaper per patient in annual costs, depending on how expenses were measured.
So we see that the major advantage to the newer drugs is their benefit to the corporate profit margin.
Wednesday, November 19, 2003
Health Workers kept silent due to fear for their lives
Five workers who made false accounting entries during a huge fraud at HealthSouth Corp. kept silent out of fear after realizing the company was buying guns, grenades and spy equipment, according to testimony Wednesday at the first sentencing in the case.
While not specifically a psychiatric fraud case, it does reveal the criminal nature of some in the health care industry. Read the full story here.
Monday, November 17, 2003
Utah State Psych Hospitals Unsafe?
The Deseret News has this report on the safety issues at state psychiatric hospital facilities in Utah. One on the major elements is that the facilities are not really trying to help people, but are acting more like prisons in disguise instead. The story offers extensive details on the horror story. This is about dangers to both the patients and the staff. Do they even know what they are doing?
More clinical and counseling psychology practices are going out of business than ever before
According to this new article on About.com, more clinical and counseling psychology practices are going out of business than ever before. This, combined with increasing numbers of graduates in the filed, leads the website to offer cautionary advice to people looking to psychology as a career path. While the author is not ready to recommend people avoid studying psychology as a career path, he recommending that people look at other areas to help keep their career options open.
Thursday, November 13, 2003
Psychiatric Malpractice in Hawaii
This special report in the The Honolulu Star-Bulletin just came to our attention
Robert Kratzke initially believed that psychiatrist Martin H. Stein was "trying to do the best" for him, his wife and family. But less than five years after Stein began treating them with dozens of psychiatric drugs, Robert's wife, Anita, was dead, Robert had gone from a top engineer to "a vegetable on the couch with a chemical lobotomy" and Chris, his youngest son, had been on 23 prescribed drugs in five years.
Mr. Kratzke and his sons are recovering, and have filed a malpractice lawsuit against Stein over Anita's death.
Tuesday, November 11, 2003
Asia's mental heath centers
Asia's mental heath centers look more like prisons than hospitals. Everyone should check out the Time Asia photoessay which exposes this travesty.
Read the story here
It is truly a hell hole.
Monday, November 10, 2003
Psych Drugs of 4 patients switched without OK
A follow up to the earlier story:
A doctor at a state mental health facility changed patients' medications last year so that they would be eligible for a study of a new psychiatric drug, violating basic guidelines for research on human subjects and causing dangerous side effects in a 43-year-old man with schizophrenia, a state investigation has found.
The Disabled Persons Protection Commission uncovered numerous ethical violations at the Solomon Carter Fuller Mental Health Center by Boston Medical Center physicians contracted to treat patients there.
According to a DPPC report, patients' medications were switched without informed consent and without a clear medical need, the changes were made more than two months before the human-studies review boards approved the research protocol, and the patients involved were clearly not eligible under the criteria for the study, which specified that subjects be outpatients.
One of the four patients whose medication was switched, a man who had been stable for 10 years on the drug Clozaril, became so ill and acutely psychotic that he spent months in and out of hospital wards. He was diagnosed with neuroleptic malignant syndrome, a rare, sometimes lethal side effect of medication changes, according to the commission's report.
The names of doctors involved were deleted from the commission report, but Department of Mental Health officials and Hughes acknowledged their identities. According to the Globe story the Doctors involved are Dr. Douglas Hughes and Dr. Valentina Jalynytchev.
The rapid decline of a patient under psych care
This story in today's Boston Globe cite the rapid decline of a patient under psych care
Medical records from the Solomon Carter Fuller Mental Health Center tell the story of a profoundly disabled patient who was ushered into a clinical trial during a single conversation: On Oct. 31, 2002, Dr. Valentina Jalynytchev sat down with the 43-year-old patient and, as she noted in a progress report, "discussed . . . clinical trial of [Risperdal]," and agreed that he would participate, according to a state report. [...]
In her notes of Oct. 31, Jalynytchev concludes that the patient was enthusiastic about starting Risperdal, which does not require regular blood tests, as Clozaril does: "He will start Risperidone . . . any time soon [it is his treatment plan], but for the study his guardian . . . needs to sign a consent form."
In fact, his treatment plan included other antipsychotic medications but not Risperdal. No call was made to his guardian. But he was started on Risperdal five days later, on Nov. 4, 2002. [...]
Which was just the start of a long, sad, horror story.
The switch in medications was the beginning of a long slide. [...] When the patient returned to the Fuller [after a trip to the emergency room] in March, he was so sensitive to antipsychotic medication that he could take only tiny doses. Doctors prescribed electroconvulsive therapy.
A Look at the Mental Health Agenda
Berit Kjos has an interesting collection of of well documented articles investigating the agenda of the mental health crowd. She entitles it the Does Your 'Mental Health' Meet Global Standards? Series.
Article One: Legalizing Mind Control
Article Two: Legalizing Mind Control 2
Therw are links to other articles as well. While you may not agree with her particular biases, the quotes are well documented, and raise the interesting question of whose global standards are they, anyhow? As she notes:
Good medical doctors naturally encourage prevention. They would want their patients to maintain health and strength. But when socialist "change agents" step into the picture with their psycho-social brainwashing strategies -- calling their agenda "prevention" in order to gain your approval -- they bring oppression instead of peace.
It gets into questions like: What agenda are they pushing. and whose should it be? She introduces one of her articles with a quote from Betrand Russle, from a book published back in 1953:
"...the subject which will be of most importance politically is Mass Psychology.... The populace will not be allowed to know how its convictions were generated. When the technique has been perfected, every government that has been in charge of education for a generation will be able to control its subjects securely without the need of armies or policemen. As yet there is only one country which has succeeded in creating this politician's paradise."[2] -- Bertrand Russell, The Impact of Science on Society (New York: Simon & Schuster, 1953); page 30.)
So whose agenda is it?
Sunday, November 09, 2003
Eugenics and the Nazis -- the California connection
As seen in the SF Chronicle
the concept of a white, blond-haired, blue-eyed master Nordic race didn't originate with Hitler. The idea was created in the United States, and cultivated in California, decades before Hitler came to power. California eugenicists played an important, although little-known, role in the American eugenics movement's campaign for ethnic cleansing. [...]
Eugenics would have been so much bizarre parlor talk had it not been for extensive financing by corporate philanthropies, specifically the Carnegie Institution, the Rockefeller Foundation and the Harriman railroad fortune. They were all in league with some of America's most respected scientists from such prestigious universities as Stanford, Yale, Harvard and Princeton. These academicians espoused race theory and race science, and then faked and twisted data to serve eugenics' racist aims.
a worthy read